10Feb
The LHD/ERISA Advisor: Sixth Circuit Rejects MSPA and ERISA Discrimination Claims
Seeking to control healthcare costs, many group health plans have adopted amendments that lower reimbursement rates for the treatment of end-stage renal disease ("ESRD"), which requires long-term dialysis treatment or a kidney transplant, resulting...
By:
Hinshaw & Culbertson LLP
Related
Philadelphia and Pittsburgh issued guidance on Wednesday, April 29 for the May 1 resumption of const...
Read More >
The litigator's secret weapon: good manners. William Hanson, the etiquette columnist for the Daily ...
Read More >
The United States Environmental Protection Agency (“EPA”) published a March 9th Federal Register N...
Read More >
California recently approved Assembly Bill 1554, adding a flexible spending account notice requireme...
Read More >
Proposed regulations, if adopted, would impose substantial restrictions in many cases on a corporati...
Read More >
In this edition of Orrick’s series of life sciences publications, the traditional update on broader...
Read More >